Published in Cancer Weekly, April 19th, 2011
"Of these, the median five-year survival rate is still less than 20%, with most resections...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.